The results showed that the tail-vein injection of aT-sEVs almost doubled tumour growth and shortened the lifespan of mice in vivo, which was rescued by preblocking PD-1/CD80 on aT-sEVs (Fig. 2b–d and Supplementary Fig. 3a, b). Here, PDCD1 is linked to neoplasm.